Reduced toxicity and improved antitumor effects for IL-2 when coadministered with M-40403 July 14, 2003
Potential new molecularly targeted therapies for diseases related to activated PDGFR-alpha July 14, 2003
Beneficial effects described for bortezomib in patients with relapsed, refractory myeloma July 14, 2003
RSS